Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Brain : a journal of neurology

• Publication date

  1996-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/BRAIN/119.1.213PMID 8624683
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission

  2004cited by this paper
• Increased mRNA Expression of IL‐10 in Mononuclear Cells in Multiple Sclerosis and Optic Neuritis

  1995cited by this paper
• Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activity

  1995cited by this paper
• Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-beta.

  1994cited by this paper
• Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-γ, interleukin-4 and transforming growth factor-β

  1994cited by this paper
• Increased transforming growth factor‐β, interleukin‐4, and interferon‐γ in multiple sclerosis

  1994cited by this paper
• Optic neuritis: findings on MRI, CSF examination and HLA class II typing in 60 patients and results of a short-term follow-up

  1994cited by this paper
• Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

  1994cited by this paper
• Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis.

  1993cited by this paper
• Interferon γ- and interleukin-4-secreting cells in multiple sclerosis

  1993cited by this paper
• Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide

  1993cited by this paper
• Number of interleukin‐4‐ and interferon‐γ‐secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation

  1993cited by this paper
• Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.

  1993cited by this paper
• Perforin and tumor necrosis factor alpha in the pathogenesis of experimental allergic encephalomyelitis: comparison of autoantigen induced and transferred disease in Lewis rats.

  1993cited by this paper
• In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis.

  1992cited by this paper
• Sensitive mRNA detection using unfixed tissue: combined radioactive and non-radioactive in situ hybridization histochemistry

  1992cited by this paper
• The pathophysiology of tumor necrosis factors.

  1992cited by this paper
• Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain

  1992cited by this paper
• Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls

  1991cited by this paper
• Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.

  1991cited by this paper
• Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.

  1991cited by this paper
• Anti—tumor necrosis factor therapy abrogates autoimmune demyelination

  1991cited by this paper
• Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains

  1991cited by this paper
• Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis.

  1991cited by this paper
• Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin.

  1991cited by this paper
• Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

  1991cited by this paper
• Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis.

  1991cited by this paper
• Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

  1991cited by this paper
• Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity.

  1990cited by this paper
• Cytokine accumulations in CSF of multiple sclerosis patients

  1990cited by this paper
• Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.

  1990cited by this paper
• An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

  1990cited by this paper
• Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus.

  1989cited by this paper
• Tumor necrosis factor alpha (TNF alpha) and neurological diseases. Failure in detecting TNF alpha in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours.

  1989cited by this paper
• Tumor necrosis factor identified in multiple sclerosis brain

  1989cited by this paper
• The biology of cachectin/TNF--a primary mediator of the host response.

  1989cited by this paper
• Tumor necrosis factor in serum and cerebrospinal fluid of patients with multiple sclerosis

  1989cited by this paper
• Tumor necrosis factor alpha (TNFα) and neurological diseases Failure in detecting TNFα in the cerebrospinal fluid from patients with multiple sclerosis, AIDS dementia complex, and brain tumours

  1989cited by this paper
• Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro

  1988cited by this paper
• Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?

  1988cited by this paper
• The role of lymphotoxin in T-cell-mediated cytotoxicity.

  1987cited by this paper
• Origin of the autoreactive anti-type II collagen response. I. Frequency of specific and multispecific B cells in primed murine lymph nodes.

  1987cited by this paper
• Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors

  1986cited by this paper
• Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification.

  1984cited by this paper
• Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity

  1984cited by this paper
• Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

  1984cited by this paper
• Rating neurologic impairment in multiple sclerosis

  1983cited by this paper
• Two subsets of rat T lymphocytes defined with monoclonal antibodies

  1980cited by this paper
• Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

  1977cited by this paper
• Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

  1972cited by this paper
• PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

  1965cited by this paper

• The Effect of Exercise on Myokine Levels in Multiple Sclerosis: IL-6, BDNF, Irısın and TNF- α

  2026cites this paper
• Serum levels of tumor necrosis factor and TNFRSF1A gene polymorphisms in Egyptian multiple sclerosis patients: the influence on susceptibility and severity.

  2025cites this paper
• iPSC-derived reactive astrocytes from patients with multiple sclerosis protect cocultured neurons in inflammatory conditions

  2023cites this paper
• Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration

  2021influential citation
• Re-Examining the Role of TNF in MS Pathogenesis and Therapy

  2020cites this paper
• Effects of IFN-β1a and IFN-β1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis

  2017cites this paper
• Cerebrospinal Fluid Markers in Neuroinflammation: The Paradigm of Optic Neuritis

  2017cites this paper
• An insight into lymphotoxin and TNF-α role in neuroinflammatory neurodegenerative diseases

  2017cites this paper
• Exosomes from HIV-1-infected Cells Stimulate Production of Pro-inflammatory Cytokines through Trans-activating Response (TAR) RNA*

  2015cites this paper
• Czynnik martwicy nowotworów alfa (TNF-α) jako potencjalny osoczowy marker przebiegu stwardnienia rozsianego – badania wstępne

  2014cites this paper
• A Biomaterials Approach for an Ex-Vivo Multiple Sclerosis Model of Inflammatory Demyelination

  2013cites this paper
• Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study

  2013cites this paper
• Fractalkine Induces the Expression of Intercellular Adhesion Molecule-1 on CD4+ T-lymphocytes: implications for the immunopathogenesis of Multiple Sclerosis

  2012cites this paper
• The effect of interleukin 17 on oligodendrocyte proliferation and differentiation

  2012cites this paper
• Correlation of Optic Neuritis with Multiple Sclerosis and Evaluating the Response of Optic Neuritis Treatment of Hospitalized Patients with Ophthalmologic Complaints in Imam and Motahari Hospitals of Urmia, Northwest Iran

  2012cites this paper
• Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L

  2011cites this paper
• The effects of high dose interferon-β1a on plasma microparticles: Correlation with MRI parameters

  2011cites this paper
• How do immune cells overcome the blood–brain barrier in multiple sclerosis?

  2011cites this paper
• Transgenic Expression of Viral Capsid Proteins Predisposes to Axonal Injury in a Murine Model of Multiple Sclerosis

  2011cites this paper
• Immunomodulatory effects of hepatocyte growth factor in experimental autoimmune encephalomyelitis

  2010cites this paper
• Induction of lymphotoxin‐α by interleukin‐12 p40 homodimer, the so‐called biologically inactive molecule, but not IL‐12 p70

  2009cites this paper
• Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis

  2009cites this paper
• TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model.

  2008cites this paper
• Cytokines in Demyelinating Diseases

  2008cites this paper
• Molecular Analysis of Cytokines and Cytokine Receptors

  2006cites this paper
• Plasma osteopontin levels in multiple sclerosis.

  2005cites this paper
• Immunology of multiple sclerosis.

  2005cites this paper
• sclerosisdifferent clinical phenotypes of multiple ß endorphin concentrations in PBMC of patients

  2005cites this paper
• Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis.

  2005cites this paper
• Astroglial‐derived lymphotoxin‐α exacerbates inflammation and demyelination, but not remyelination

  2005cites this paper
• Estudio de la osteopontina en la esclerosis múltiple y su relación con la progresión de la enfermedad

  2004cites this paper
• β endorphin concentrations in PBMC of patients with different clinical phenotypes of multiple sclerosis

  2003cites this paper
• Role of cytokines in neurological disorders.

  2003cites this paper
• Antibodies to myelin basic protein, myelin oligodendrocytes peptides, α‐β‐crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis

  2003cites this paper
• Estudio inmunológico en la esclerosis múltiple familiar citocinas, moléculas de adhesión y receptores de quimiocinas

  2003cites this paper
• The immunomodulatory properties of in vitro immunoglobulins are dose‐dependent

  2003cites this paper
• Depletion of Vβ5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis

  2002cites this paper
• Oligodendrocyte Glycoprotein: A Multiple The Human T Cell Response to Myelin

  2002cites this paper
• The Human T Cell Response to Myelin Oligodendrocyte Glycoprotein: A Multiple Sclerosis Family-Based Study1

  2002cites this paper
• Optic neuritis in multiple sclerosis

  2002cites this paper
• Monocyte/macrophage initiation of organ-specific autoimmunity: the ultimate 'bystander' hypothesis?

  2002cites this paper
• Depletion of Vbeta5.2/5.3 T cells with a humanized antibody in patients with multiple sclerosis.

  2002cites this paper
• Cytokines in multiple sclerosis: methodological aspects and pathogenic implications

  2002cites this paper
• Interferon beta-1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis.

  2002cites this paper
• Interferon β-1b modulates MCP-1 expression and production in relapsing–remitting multiple sclerosis

  2002cites this paper
• Multiple Sclerosis: Ethics, Outcome Variables and Clinical Scales

  2001cites this paper
• Characterization of early immunological responses in primary cultures of differentially activated human peripheral mononuclear cells.

  2001cites this paper
• EXPRESSION OF TNF-α mRNA BY PERIPHERAL BLOOD MONONUCLEAR CELLS OF MULTIPLE SCLEROSIS PATIENTS TREATED WITH IFN-β 1A

  2001cites this paper
• Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease.

  2001cites this paper
• Antigen Specific Immunotherapy of Multiple Sclerosis

  2001cites this paper
• Clues to the immunopathogenesis of multiple sclerosis by investigating untreated patients during the very early stage of disease

  2001cites this paper
• Expression of TNF-alpha mRNA by peripheral blood mononuclear cells of multiple sclerosis patients treated with IFN-beta 1A.

  2001cites this paper
• Matrix-degrading metalloproteinases and cytokines in multiple sclerosis and ischemic stroke

  2001influential citation
• Beneficial effect of co‐polymer 1 on cytokine production by CD4 T cells in multiple sclerosis

  2001cites this paper
• Tumor necrosis factor-α expression in muscles of polymyositis and dermatomyositis

  2000cites this paper
• Tumor necrosis factor-alpha binding by peripheral blood lymphocytes and polymorphonuclear neutrophils in patients with multiple sclerosis.

  2000cites this paper
• Inducible nitric oxide synthase expression elicited in the mouse brain by inflammatory mediators circulating in the cerebrospinal fluid.

  2000cites this paper
• Augmented type 1 cytokines and human endogenous retroviruses specific immune responses in patients with acute multiple sclerosis.

  2000cites this paper
• Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis.

  2000cites this paper
• Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

  2000cites this paper
• Multiple sclerosis is associated with an imbalance between tumour necrosis factor‐alpha (TNF‐α)‐ and IL‐10‐secreting blood cells that is corrected by interferon‐beta (IFN‐β) treatment

  2000cites this paper
• Tumor necrosis factor-alpha expression in muscles of polymyositis and dermatomyositis.

  2000cites this paper
• Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group.

  2000cites this paper
• Changes in plasma cytokines induced by interferon-beta1a treatment in patients with multiple sclerosis.

  1999cites this paper
• The immunobiology of multiple sclerosis: an autoimmune disease of the central nervous system.

  1999cites this paper
• Quantitative PCR Reveals Increased Levels of Tumor Necrosis Factor-alpha mRNA in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients During Relapses

  1999cites this paper
• The role of TNFalpha and lymphotoxin in demyelinating disease.

  1999cites this paper
• Immunological surrogate markers of disease activity in multiple sclerosis.

  1999cites this paper
• Altered nerve growth factor level in the optic nerve of patients affected by multiple sclerosis

  1999cites this paper
• Immune responses to antigens of human endogenous retroviruses in patients with acute or stable multiple sclerosis.

  1999cites this paper
• Expression of Lymphotoxin Gene Inserted into Theiler's Murine Encephalomyelitis Virus

  1999cites this paper
• Expression of costimulatory molecules and cytokines in CSF and peripheral blood mononuclear cells from multiple sclerosis patients.

  1999cites this paper
• Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

  1999cites this paper
• Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines.

  1999cites this paper
• Demyelination: The Role of Reactive Oxygen and Nitrogen Species

  1999cites this paper
• The role of TNFα and lymphotoxin in demyelinating disease

  1999cites this paper
• Beta chemokine expression and regulation of lymphocyte traffic at the blood-brain barrier

  1999cites this paper
• Maturation of oligodendrocytes is more sensitive to TNF alpha than is survival of precursors and immature oligodendrocytes.

  1999cites this paper
• The role of TNF (cid:225) and lymphotoxin in demyelinating disease

  1999cites this paper
• The role of TNF (cid:225) and lymphotoxin in demyelinating disease

  1999cites this paper
• Evidence that brain mast cells can modulate neuroinflammatory responses by tumour necrosis factor‐α production

  1998cites this paper
• Linomide (roquinimex) affects the balance between pro‐ and anti‐inflammatory cytokines in vitro in multiple sclerosis

  1998cites this paper
• Acute Multiple Sclerosis Molecule (SLAM)-Expressing Lymphocytes in Augmented Signaling Lymphocytic Activation Sclerosis: Altered IL-12 Production and Expression in Acute and Stable Multiple Cytokine Production and Surface Marker

  1998cites this paper
• Influence of IFN‐β1b (Betaferon) on cytokine mRNA profiles in blood mononuclear cells and plasma levels of soluble VCAM‐1 in multiple sclerosis

  1998cites this paper
• Elevated serum levels of IFN-γ, IL-4 and TNF-α/ unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage

  1998cites this paper
• Data on cytokine mRNA expression in CSF and peripheral blood mononuclear cells from MS patients as detected by PCR

  1998cites this paper
• The cytokine storm in multiple sclerosis

  1998cites this paper
• Cytokine production and surface marker expression in acute and stable multiple sclerosis: altered IL-12 production and augmented signaling lymphocytic activation molecule (SLAM)-expressing lymphocytes in acute multiple sclerosis.

  1998cites this paper
• TCR repertoire and cytokine profiles of cerebrospinal fluid– and peripheral blood–derived T lymphocytes from patients with multiple sclerosis

  1998cites this paper
• Cultured human monocytes release proinflammatory cytokines in response to myelin basic protein.

  1998cites this paper
• Interleukin‐12 and Perforin mRNA Expression is Augmented in Blood Mononuclear Cells in Multiple Sclerosis

  1998cites this paper
• Cytokines, Signal Transduction, and Inflammatory Demyelination: Review and Hypothesis

  1998cites this paper
• Strategies for the therapeutic manipulation of cytokines and their receptors in inflammatory neurodegenerative diseases

  1998cites this paper
• Optic neuritis and cytokines

  1998cites this paper
• Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage.

  1998cites this paper
• SB 207499 (Ariflo), a second generation phosphodiesterase 4 inhibitor, reduces tumor necrosis factor alpha and interleukin-4 production in vivo.

  1998cites this paper
• The phosphodiesterase i.v. inhibitor rolipram in vitro reduces the numbers of MBP-reactive IFN-gamma and TNF-alpha mRNA expressing blood mononuclear cells in patients with multiple sclerosis.

  1998cites this paper
• Linomide suppresses chronic-relapsing experimental autoimmune encephalomyelitis in DA rats.

  1998cites this paper
• Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist.

  1998cites this paper
• Multiple sclerosis: myelin basic protein induced mRNA expression of proinflammatory cytokines in mononuclear cells is suppressed by interferon‐β 1b in vitro

  1997cites this paper